Helen Plant
AstraZeneca (Brazil)(BR)
Publications by Year
Research Areas
Bacterial Genetics and Biotechnology, Ubiquitin and proteasome pathways, Protein Kinase Regulation and GTPase Signaling, Computational Drug Discovery Methods, 3D Printing in Biomedical Research
Most-Cited Works
- → Paradoxical activation of Raf by a novel Raf inhibitor(1999)265 cited
- → Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides(2018)129 cited
- → Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis(2017)124 cited
- → Identification and Characterization of Dual Inhibitors of the USP25/28 Deubiquitinating Enzyme Subfamily(2017)85 cited
- → Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT(2012)51 cited
- → Development of a High-Throughput Fluorescence Polarization DNA Cleavage Assay for the Identification of FEN1 Inhibitors(2013)24 cited
- → A Novel High-Throughput Cell-Based Assay Aimed at Identifying Inhibitors of DNA Metabolism in Bacteria(2014)22 cited
- → Advancing automation in high-throughput screening: Modular unguarded systems enable adaptable drug discovery(2022)21 cited
- → Enabling 1536-Well High-Throughput Cell-Based Screening through the Application of Novel Centrifugal Plate Washing(2017)20 cited
- → Development of a high-throughput replicon assay for the identification of respiratory syncytial virus inhibitors(2013)17 cited